Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 3, 2021 7:02 AM 3 min read

22 Stocks Moving in Monday's Pre-Market Session

by Lisa Levin Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Gainers


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Image Sensing Systems, Inc. (NASDAQ:ISNS) fell 5.5% to $6.16 in pre-market trading. Image Sensing Systems shares jumped 42% on Friday after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000 share buyback and announced the implementation of a holding company reorganization.
  • Salem Media Group, Inc. (NASDAQ:SALM) shares fell 5.5% to $1.90 in pre-market trading after dropping over 4% on Friday.
  • Torchlight Energy Resources, Inc. (NASDAQ:TRCH) fell 5% to $2.01 in pre-market trading after dropping around 9% on Friday.
  • Sanofi (NASDAQ:SNY) fell 4.5% to $50.02 in pre-market trading.
  • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 4.4% to $2.18 in pre-market trading. Plus Therapeutics, last month, reported a Q1 loss of $0.33 per share.
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasHealth CarePharmaceuticalsPre-Market MoversTop Gainers
ABCL Logo
ABCLAbCellera Biologics Inc
$3.211.58%
Overview
AHT Logo
AHTAshford Hospitality Trust Inc
$3.550.85%
BCTX Logo
BCTXBriaCell Therapeutics Corp
$4.14-0.96%
BTX Logo
BTXBlackRock Technology and Private Equity Term Trust
$6.39-2.44%
ENLV Logo
ENLVEnlivex Therapeutics Ltd
$1.15-0.86%
FAMI Logo
FAMIFarmmi Inc
$1.18-0.84%
GOVX Logo
GOVXGeovax Labs Inc
$2.63-1.50%
PLX Logo
PLXProtalix BioTherapeutics Inc
$2.87-0.69%
PSTV Logo
PSTVPlus Therapeutics Inc
$0.2500-3.81%
SALM Logo
SALMSalem Media Group Inc
$0.400045.3%
SNY Logo
SNYSanofi SA
$47.80-0.07%
VINO Logo
VINOGaucho Group Holdings Inc
$2.00-%
VRPX Logo
VRPXVirpax Pharmaceuticals Inc
$0.0107-98.4%
VXRT Logo
VXRTVaxart Inc
$0.600089.7%
  • Brooklyn ImmunoTherapeutics, Inc. (NYSE:BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn ImmunoTherapeutics. The company, on April 26, entered into a purchase agreement with Lincoln Park Capital Fund under which the company may sell up to $200 million of common stock to Lincoln Park.
  • Regional Health Properties, Inc. (NYSE:RHE) rose 24.2% to $8.97 in pre-market trading after jumping 38% on Friday.
  • Gaucho Group Holdings, Inc. (NASDAQ:VINO) rose 17.5% to $5.10 in pre-market trading after climbing 19% on Friday.
  • Vaxart, Inc. (NASDAQ:VXRT) rose 15.6% to $12.46 in pre-market trading after adding 17% in the previous session.
  • Ashford Hospitality Trust, Inc. (NYSE:AHT) shares rose 13.2% to $3.10 in pre-market trading after jumping over 13% on Friday.
  • Enlivex Therapeutics Ltd. (NASDAQ:ENLV) rose 12.2% to $12.84 in pre-market trading after dropping over 5% on Friday.
  • Meredith Corporation (NYSE:MDP) rose 11.9% to $34.80 in pre-market trading. The company, last week, reported Q3 results.
  • BriaCell Therapeutics Corp. (NASDAQ:BCTX) rose 11.1% to $4.10 in pre-market trading after gaining more than 6% on Friday.
  • Farmmi, Inc. (NASDAQ:FAMI) rose 7.9% to $0.4810 in pre-market trading after jumping around 25% on Friday. The company, last week, announced it priced its 140 million common stock offering $0.30 per share.
  • GeoVax Labs, Inc. (NASDAQ:GOVX) shares rose 7.7% to $5.86 in pre-market trading. GeoVax is expected to report Q1 results on May 6.
  • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares rose 7.6% to $4.27 in pre-market trading. Virpax Pharmaceuticals, last week, said it engaged Torreya Capital to advise on global partnering efforts.
  • DAVIDsTEA Inc. (NASDAQ:DTEA) rose 7.5% to $3.60 in pre-market trading following quarterly results. The company reported Q4 adjusted earnings of $0.15 per share, up from $0.13 per share in the year-ago quarter. Its total sales fell 45.3% to $40.2 million, while sales from e-commerce and wholesale channels jumped by 95.9% during the quarter.
  • Novan, Inc. (NASDAQ:NOVN) rose 7.3% to $1.47 in pre-market trading. Roth Capital, last week, initiated coverage on the stock with a Buy rating and announced a $3 price target.
  • Protalix BioTherapeutics, Inc. (NYSE:PLX) rose 7.2% to $3.59 in pre-market trading. The company, last week, announced it received a Complete Response Letter for its Pegunigalsidase Alfa as a treatment for Fabry disease from the FDA.
  • U.S. Well Services, Inc. (NASDAQ:USWS) shares rose 7.1% to $0.88 in pre-market trading after declining 6% on Friday.
  • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) rose 5.9% to $4.13 in pre-market trading as the company announced new long-term data from the OPTIC Phase 1 trial of ADVM-022 single intravitreal (IVT) injection gene therapy in patients with neovascular or wet age-related macular degeneration (wet AMD).
  • AbCellera Biologics Inc. (NASDAQ:ABCL) rose 5.1% to $28.00 in pre-market trading. The company is scheduled to release Q1 results on May 13.
ABCL Logo
ABCLAbCellera Biologics Inc
$3.211.58%
Overview
AHT Logo
AHTAshford Hospitality Trust Inc
$3.550.85%
BCTX Logo
BCTXBriaCell Therapeutics Corp
$4.14-0.96%
BTX Logo
BTXBlackRock Technology and Private Equity Term Trust
$6.39-2.44%
ENLV Logo
ENLVEnlivex Therapeutics Ltd
$1.15-0.86%
FAMI Logo
FAMIFarmmi Inc
$1.18-0.84%
GOVX Logo
GOVXGeovax Labs Inc
$2.63-1.50%
PLX Logo
PLXProtalix BioTherapeutics Inc
$2.87-0.69%
PSTV Logo
PSTVPlus Therapeutics Inc
$0.2500-3.81%
SALM Logo
SALMSalem Media Group Inc
$0.400045.3%
SNY Logo
SNYSanofi SA
$47.80-0.07%
VINO Logo
VINOGaucho Group Holdings Inc
$2.00-%
VRPX Logo
VRPXVirpax Pharmaceuticals Inc
$0.0107-98.4%
VXRT Logo
VXRTVaxart Inc
$0.600089.7%
Comments
Loading...